Intellectual Property India Publishes Patent Application for 'Kras Inhibitors' Filed by Eli Lilly And Company

MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202517074739 A) filed by Eli Lilly And Company, Indianapolis, on Aug. 6, for 'kras inhibitors.'

Inventor(s) include Abraham, Adedoyin David; Valero De La Cruz, Alberto; Dilger, Andrew; Bume, Desta; Priego Soler, Julian; Prieto Vallejo, Maria Lourdes; Barberis, Mario; Garzon Sanz, Miguel; Rajamani, Ramkumar; Aronow, Sean; Walls, Shane Michael; Gutierrez Sanfeliciano, Sonia Maria; Kercher, Timothy Scott; Molero Florez, Victoriano; and Chen, Xiaohong.

The application for the patent was published on Oct. 10, under issue no. 41/2025.

According to the abstract released by the Intellectual Property India: "The present invention provides compounds of the formula (I) wherein A, Z, G, R1, R2, and R4 are as described herein, pharmaceutically acceptable salts thereof, and methods of using these compounds and pharmaceutically acceptable salts thereof for treating patients for cancer."

The patent application was internationally filed on Mar. 29, 2024, under International application No.PCT/US2024/022131.

Disclaimer: Curated by HT Syndication.